Myomo Inc Stock Analysis

MYO Stock  USD 5.31  0.13  2.39%   
Myomo Inc is undervalued with Real Value of 6.56 and Hype Value of 5.32. The main objective of Myomo stock analysis is to determine its intrinsic value, which is an estimate of what Myomo Inc is worth, separate from its market price. There are two main types of Myomo's stock analysis: fundamental analysis and technical analysis.
The Myomo stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Myomo is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Myomo Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Myomo Stock Analysis Notes

About 59.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Myomo Inc last dividend was issued on the 31st of January 2020. The entity had 1:30 split on the 31st of January 2020. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. Myomo operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 87 people. To find out more about Myomo Inc contact Paul Gudonis at 617 996 9058 or learn more at https://myomo.com.

Myomo Inc Investment Alerts

Myomo Inc generated a negative expected return over the last 90 days
Myomo Inc has high historical volatility and very poor performance
The company reported the last year's revenue of 32.55 M. Reported Net Loss for the year was (6.18 M) with profit before taxes, overhead, and interest of 23.19 M.
Myomo Inc has about 5.35 M in cash with (3.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
Myomo Inc has a frail financial position based on the latest SEC disclosures
Roughly 59.0% of the company shares are owned by institutional investors

Myomo Inc Upcoming and Recent Events

Earnings reports are used by Myomo to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
11th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Myomo Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 187.03 M.

Myomo Profitablity

The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.02) %, which entails that for every $100 of revenue, it lost $0.02.

Technical Drivers

As of the 19th of March, Myomo secures the Mean Deviation of 3.41, standard deviation of 6.42, and Risk Adjusted Performance of 0.0085. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Myomo Inc, as well as the relationship between them.

Myomo Inc Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Myomo middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Myomo Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Myomo Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Myomo insiders, such as employees or executives, is commonly permitted as long as it does not rely on Myomo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Myomo insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Myomo Outstanding Bonds

Myomo issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Myomo Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Myomo bonds can be classified according to their maturity, which is the date when Myomo Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Myomo Predictive Daily Indicators

Myomo intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Myomo stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Myomo Forecast Models

Myomo's time-series forecasting models are one of many Myomo's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Myomo's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Myomo Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Myomo prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Myomo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Myomo. By using and applying Myomo Stock analysis, traders can create a robust methodology for identifying Myomo entry and exit points for their positions.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. Myomo operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 87 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Myomo to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.